142 related articles for article (PubMed ID: 32370941)
1. Severe-malaria infection and its outcomes among pregnant women in Burkina Faso health-districts: Hierarchical Bayesian space-time models applied to routinely-collected data from 2013 to 2018.
Rouamba T; Samadoulougou S; Tinto H; Alegana VA; Kirakoya-Samadoulougou F
Spat Spatiotemporal Epidemiol; 2020 Jun; 33():100333. PubMed ID: 32370941
[TBL] [Abstract][Full Text] [Related]
2. Bayesian Spatiotemporal Modeling of Routinely Collected Data to Assess the Effect of Health Programs in Malaria Incidence During Pregnancy in Burkina Faso.
Rouamba T; Samadoulougou S; Tinto H; Alegana VA; Kirakoya-Samadoulougou F
Sci Rep; 2020 Feb; 10(1):2618. PubMed ID: 32060297
[TBL] [Abstract][Full Text] [Related]
3. Malaria prevention during pregnancy: assessing the disease burden one year after implementing a program of intermittent preventive treatment in Koupela District, Burkina Faso.
Sirima SB; Cotte AH; Konaté A; Moran AC; Asamoa K; Bougouma EC; Diarra A; Ouédraogo A; Parise ME; Newman RD
Am J Trop Med Hyg; 2006 Aug; 75(2):205-11. PubMed ID: 16896120
[TBL] [Abstract][Full Text] [Related]
4. [Intermittent preventive treatment with sulfadoxine--pyrimethamine for malaria in pregnant women: efficacy and compliance in two urban hospitals in Burkina Faso].
Bamba S; Séré A; Nikiéma R; Halidou T; Thiéba B; Dao B; Guiguemdé RT
Pan Afr Med J; 2013; 14():105. PubMed ID: 23717719
[TBL] [Abstract][Full Text] [Related]
5. Parasite clearance following treatment with sulphadoxine-pyrimethamine for intermittent preventive treatment in Burkina-Faso and Mali: 42-day in vivo follow-up study.
Coulibaly SO; Kayentao K; Taylor S; Guirou EA; Khairallah C; Guindo N; Djimde M; Bationo R; Soulama A; Dabira E; Barry B; Niangaly M; Diakite H; Konate S; Keita M; Traore B; Meshnick SR; Magnussen P; Doumbo OK; ter Kuile FO
Malar J; 2014 Jan; 13():41. PubMed ID: 24484467
[TBL] [Abstract][Full Text] [Related]
6. Community-based promotional campaign to improve uptake of intermittent preventive antimalarial treatment in pregnancy in Burkina Faso.
Gies S; Coulibaly SO; Ky C; Ouattara FT; Brabin BJ; D'Alessandro U
Am J Trop Med Hyg; 2009 Mar; 80(3):460-9. PubMed ID: 19270299
[TBL] [Abstract][Full Text] [Related]
7. An analysis of timing and frequency of malaria infection during pregnancy in relation to the risk of low birth weight, anaemia and perinatal mortality in Burkina Faso.
Valea I; Tinto H; Drabo MK; Huybregts L; Sorgho H; Ouedraogo JB; Guiguemde RT; van Geertruyden JP; Kolsteren P; D'Alessandro U;
Malar J; 2012 Mar; 11():71. PubMed ID: 22433778
[TBL] [Abstract][Full Text] [Related]
8. Impact of intermittent preventive treatment of malaria in pregnancy with dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine on the incidence of malaria in infancy: a randomized controlled trial.
Kakuru A; Jagannathan P; Kajubi R; Ochieng T; Ochokoru H; Nakalembe M; Clark TD; Ruel T; Staedke SG; Chandramohan D; Havlir DV; Kamya MR; Dorsey G
BMC Med; 2020 Aug; 18(1):207. PubMed ID: 32772921
[TBL] [Abstract][Full Text] [Related]
9. Mefloquine for preventing malaria in pregnant women.
González R; Pons-Duran C; Piqueras M; Aponte JJ; Ter Kuile FO; Menéndez C
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD011444. PubMed ID: 29561063
[TBL] [Abstract][Full Text] [Related]
10. An ethnographic study of how health system, socio-cultural and individual factors influence uptake of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine in a Ghanaian context.
Aberese-Ako M; Magnussen P; Ampofo GD; Gyapong M; Ansah E; Tagbor H
PLoS One; 2021; 16(10):e0257666. PubMed ID: 34618812
[TBL] [Abstract][Full Text] [Related]
11. Intermittent preventive treatment of malaria with sulphadoxine-pyrimethamine during pregnancy in Burkina Faso: effect of adding a third dose to the standard two-dose regimen on low birth weight, anaemia and pregnancy outcomes.
Valea I; Tinto H; Drabo MK; Huybregts L; Henry MC; Roberfroid D; Guiguemde RT; Kolsteren P; D'Alessandro U;
Malar J; 2010 Nov; 9():324. PubMed ID: 24576068
[TBL] [Abstract][Full Text] [Related]
12. Recent uptake of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine is associated with increased prevalence of Pfdhfr mutations in Bobo-Dioulasso, Burkina Faso.
Cisse M; Awandare GA; Soulama A; Tinto H; Hayette MP; Guiguemdé RT
Malar J; 2017 Jan; 16(1):38. PubMed ID: 28114990
[TBL] [Abstract][Full Text] [Related]
13. Individual efficacy of intermittent preventive treatment with sulfadoxine-pyrimethamine in primi- and secundigravidae in rural Burkina Faso: impact on parasitaemia, anaemia and birth weight.
Gies S; Coulibaly SO; Ouattara FT; D'Alessandro U
Trop Med Int Health; 2009 Feb; 14(2):174-82. PubMed ID: 19171009
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for Plasmodium falciparum infection in pregnant women in Burkina Faso: a community-based cross-sectional survey.
Yaro JB; Ouedraogo A; Diarra A; Sombié S; Ouedraogo ZA; Nébié I; Drakeley C; Sirima SB; Tiono AB; Lindsay SW; Wilson AL
Malar J; 2021 Sep; 20(1):362. PubMed ID: 34488770
[TBL] [Abstract][Full Text] [Related]
15. A community effectiveness trial of strategies promoting intermittent preventive treatment with sulphadoxine-pyrimethamine in pregnant women in rural Burkina Faso.
Gies S; Coulibaly SO; Ouattara FT; Ky C; Brabin BJ; D'Alessandro U
Malar J; 2008 Sep; 7():180. PubMed ID: 18801158
[TBL] [Abstract][Full Text] [Related]
16. A Non-Inferiority, Individually Randomized Trial of Intermittent Screening and Treatment versus Intermittent Preventive Treatment in the Control of Malaria in Pregnancy.
Tagbor H; Cairns M; Bojang K; Coulibaly SO; Kayentao K; Williams J; Abubakar I; Akor F; Mohammed K; Bationo R; Dabira E; Soulama A; Djimdé M; Guirou E; Awine T; Quaye S; Njie F; Ordi J; Doumbo O; Hodgson A; Oduro A; Meshnick S; Taylor S; Magnussen P; ter Kuile F; Woukeu A; Milligan P; Chandramohan D; Greenwood B
PLoS One; 2015; 10(8):e0132247. PubMed ID: 26258474
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and risk factors for Plasmodium falciparum malaria in pregnant women attending antenatal clinic in Bobo-Dioulasso (Burkina Faso).
Cisse M; Sangare I; Lougue G; Bamba S; Bayane D; Guiguemde RT
BMC Infect Dis; 2014 Nov; 14():631. PubMed ID: 25408152
[TBL] [Abstract][Full Text] [Related]
18. Presence of quintuple dhfr N51, C59, S108 - dhps A437, K540 mutations in Plasmodium falciparum isolates from pregnant women and the general population in Nanoro, Burkina Faso.
Ruizendaal E; Tahita MC; Traoré-Coulibaly M; Tinto H; Schallig HDFH; Mens PF
Mol Biochem Parasitol; 2017 Oct; 217():13-15. PubMed ID: 28818675
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and factors associated with carriage of Pfmdr1 polymorphisms among pregnant women receiving intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP) and artemether-lumefantrine for malaria treatment in Burkina Faso.
Natama HM; Toussaint R; Bazié DLC; Samadoulougou S; Coulibaly-Traoré M; Tinto H; Kirakoya-Samadoulougou F
Malar J; 2020 Nov; 19(1):399. PubMed ID: 33172485
[TBL] [Abstract][Full Text] [Related]
20. Intermittent screening and treatment with artemether-lumefantrine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria.
Esu E; Berens-Riha N; Pritsch M; Nwachuku N; Loescher T; Meremikwu M
Malar J; 2018 Jul; 17(1):251. PubMed ID: 29976228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
